1Folkman J. Tumor angiogenesis and tissue factor. Nat Med, 1996, 2(2):167.
2Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted sngiogenic mitogen. Science, 1989, 246: 1306.
3Tischer E. Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. J Biol Chem, 1991, 266: 11947.
4Houck KA, Ferrara N, Winer J. et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterizartion of alternative splicing of RNA. Mol Endocrinol, 1991; 3(12): 1806.
5Park JE, Keller GA and Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix - bound VEGF. Mol Biol Cell, 1993; 4(12): 1317.
6Pinedo HM, Vetheul HM, D Amato R J, et al. In. volvement of platelet in tumor angiogenesis? Lancet, 1998; 352(9143): 1775.
7Brock TA, Dovorak HF, Senger DR. et al. Tumor - secreted vascular permeability factor increases cytosolic Ca^2+ and von willebrand factor release in human endothelial cells. Am J Path, 1991; 138: 213.
8Dvorak HF. Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascuiar hyperpermeability and angiogenesis. Am J Path, 1995; 146: 1029.
9Anderson AR, Chaplain MA. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol, 1998; 60(5): 857.
10Kieser A, Weich HA, Brandaner G, et al. Mutant P53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 1994; 9(3): 963.
